These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21121779)

  • 1. Evaluating a newly developed pharmacogenetic array: screening in a Spanish population.
    Almoguera B; Riveiro-Alvarez R; Gomez-Dominguez B; Lopez-Rodriguez R; Dorado P; Vaquero-Lorenzo C; Dal-Ré R; Fernandez-Piqueras J; Llerena A; Abad-Santos F; Ayuso C
    Pharmacogenomics; 2010 Nov; 11(11):1619-25. PubMed ID: 21121779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip.
    Cuyàs E; Olano-Martín E; Khymenets O; Hernández L; Jofre-Monseny L; Grandoso L; Tejedor D; Martínez A; Farré M; de la Torre R
    Pharmacogenomics; 2010 Feb; 11(2):257-66. PubMed ID: 20136364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of drugs withdrawn from the market.
    Zhang W; Roederer MW; Chen WQ; Fan L; Zhou HH
    Pharmacogenomics; 2012 Jan; 13(2):223-31. PubMed ID: 22256871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chip-based genotyping: translation of pharmacogenetic research to clinical practice.
    von Ahsen N; Oellerich M
    Clin Chem; 2007 Jul; 53(7):1186-7. PubMed ID: 17582149
    [No Abstract]   [Full Text] [Related]  

  • 5. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
    Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
    Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.
    Gaedigk A; Hernandez J; García-Solaesa V; Sánchez S; Isidoro-García M
    Pharmacogenomics; 2011 Nov; 12(11):1617-22. PubMed ID: 22044417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
    Ng D; Hong CS; Singh LN; Johnston JJ; Mullikin JC; Biesecker LG
    Genet Med; 2017 Mar; 19(3):357-361. PubMed ID: 27537706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
    Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
    Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder.
    Ramey-Hartung B; El-Mallakh RS; Reynolds KK
    Clin Lab Med; 2008 Dec; 28(4):627-43. PubMed ID: 19059067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of mood disorders: what clinicians need to know.
    Laje G
    CNS Spectr; 2013 Oct; 18(5):272-84. PubMed ID: 24050155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of microarray technology in psychotropic drug trials.
    Murphy GM
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):72-8. PubMed ID: 16785274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current applications of clinical genetic testing for psychiatric practice.
    Mrazek DA
    Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
    Buzková H; Pechandová K; Slanar O; Perlík F
    Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting predictive markers for pharmacogenetic traits: tagging vs. data-mining approaches.
    Sabbagh A; Génin E; Darlu P
    Hum Hered; 2008; 66(1):10-8. PubMed ID: 18223313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacogeneticist's look at drug effects and the drug development process: an overview.
    Kalow W
    Expert Opin Pharmacother; 2005 Jul; 6(8):1299-303. PubMed ID: 16013980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric pharmacogenomic testing in clinical practice.
    Mrazek DA
    Dialogues Clin Neurosci; 2010; 12(1):69-76. PubMed ID: 20373668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.